Phenylephrine Decreases Vascular Tension in Goat Arteries in Specific Circumstances.

Phenylephrine (PE) causes vasoconstriction through alpha adrenergic receptors. PE-induced vasodilatation has also been reported earlier in pre-constricted vessels. Here we demonstrate in spiral strips of goat arteries that addition of PE can decrease tone even from base-line levels (i.e. not pre-con...

Full description

Bibliographic Details
Main Authors: Renu R Raj, Sathya Subramani
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4928870?pdf=render
id doaj-231a842c92624e32b1dec837f548362d
record_format Article
spelling doaj-231a842c92624e32b1dec837f548362d2020-11-25T00:47:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01116e015855110.1371/journal.pone.0158551Phenylephrine Decreases Vascular Tension in Goat Arteries in Specific Circumstances.Renu R RajSathya SubramaniPhenylephrine (PE) causes vasoconstriction through alpha adrenergic receptors. PE-induced vasodilatation has also been reported earlier in pre-constricted vessels. Here we demonstrate in spiral strips of goat arteries that addition of PE can decrease tone even from base-line levels (i.e. not pre-constricted) and show that this process requires nitric oxide (NO) and alpha adrenergic stimulation, but is cGMP-independent. Under control conditions, PE caused vasoconstriction, but under conditions where NO levels are higher, as with L-Arginine or sodium nitroprusside, PE decreased vessel tension. L-Arginine/PE combination was not able to decrease tension when alpha adrenoceptors were blocked with Phentolamine or endothelial nitric oxide synthase (eNOS) was blocked with Nω-Nitro-L-arginine (L-NNA). Propranolol, a beta blocker, was unable to prevent the reduction in tension by the L-Arginine/PE combination. Adrenaline and noradrenaline (and not isoproterenol) also reduced vessel tension in the presence of L-Arginine. Even when NO levels were not enhanced, relieving NO from having to stimulate the enzyme soluble guanylyl cyclase (sGC) (either by using sGC blockers, namely ODQ or methylene blue, or by enhancing cGMP levels (with sildenafil) which by negative feedback probably inhibits sGC) led to PE-induced reduction of vascular tension. PMA-phorbol myristate acetate-an agonist which stimulates Protein Kinase C was able to prevent the ability of PE to reduce vascular tension in a high NO environment. Our conclusion is that PE reduces vascular tension through alpha adrenoceptors if there is excess NO availability to activate a putative pathway. Though the reduction of vessel tone by PE is dependent on NO, it is independent of cGMP. Prior treatment with PMA or PE itself can prevent further PE-induced reduction of tension in a high NO environment. The results here suggest, counter-intuitively, that alpha blockers may be of help in the treatment of septic shock where nitric oxide levels are high.http://europepmc.org/articles/PMC4928870?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Renu R Raj
Sathya Subramani
spellingShingle Renu R Raj
Sathya Subramani
Phenylephrine Decreases Vascular Tension in Goat Arteries in Specific Circumstances.
PLoS ONE
author_facet Renu R Raj
Sathya Subramani
author_sort Renu R Raj
title Phenylephrine Decreases Vascular Tension in Goat Arteries in Specific Circumstances.
title_short Phenylephrine Decreases Vascular Tension in Goat Arteries in Specific Circumstances.
title_full Phenylephrine Decreases Vascular Tension in Goat Arteries in Specific Circumstances.
title_fullStr Phenylephrine Decreases Vascular Tension in Goat Arteries in Specific Circumstances.
title_full_unstemmed Phenylephrine Decreases Vascular Tension in Goat Arteries in Specific Circumstances.
title_sort phenylephrine decreases vascular tension in goat arteries in specific circumstances.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description Phenylephrine (PE) causes vasoconstriction through alpha adrenergic receptors. PE-induced vasodilatation has also been reported earlier in pre-constricted vessels. Here we demonstrate in spiral strips of goat arteries that addition of PE can decrease tone even from base-line levels (i.e. not pre-constricted) and show that this process requires nitric oxide (NO) and alpha adrenergic stimulation, but is cGMP-independent. Under control conditions, PE caused vasoconstriction, but under conditions where NO levels are higher, as with L-Arginine or sodium nitroprusside, PE decreased vessel tension. L-Arginine/PE combination was not able to decrease tension when alpha adrenoceptors were blocked with Phentolamine or endothelial nitric oxide synthase (eNOS) was blocked with Nω-Nitro-L-arginine (L-NNA). Propranolol, a beta blocker, was unable to prevent the reduction in tension by the L-Arginine/PE combination. Adrenaline and noradrenaline (and not isoproterenol) also reduced vessel tension in the presence of L-Arginine. Even when NO levels were not enhanced, relieving NO from having to stimulate the enzyme soluble guanylyl cyclase (sGC) (either by using sGC blockers, namely ODQ or methylene blue, or by enhancing cGMP levels (with sildenafil) which by negative feedback probably inhibits sGC) led to PE-induced reduction of vascular tension. PMA-phorbol myristate acetate-an agonist which stimulates Protein Kinase C was able to prevent the ability of PE to reduce vascular tension in a high NO environment. Our conclusion is that PE reduces vascular tension through alpha adrenoceptors if there is excess NO availability to activate a putative pathway. Though the reduction of vessel tone by PE is dependent on NO, it is independent of cGMP. Prior treatment with PMA or PE itself can prevent further PE-induced reduction of tension in a high NO environment. The results here suggest, counter-intuitively, that alpha blockers may be of help in the treatment of septic shock where nitric oxide levels are high.
url http://europepmc.org/articles/PMC4928870?pdf=render
work_keys_str_mv AT renurraj phenylephrinedecreasesvasculartensioningoatarteriesinspecificcircumstances
AT sathyasubramani phenylephrinedecreasesvasculartensioningoatarteriesinspecificcircumstances
_version_ 1725262013035184128